Restrictions on obesity drug coverage force patients to pivot
Briefly

Restrictions on obesity drug coverage force patients to pivot
"I was devastated. I had been able to get Zepbound for a $30 monthly copay and had lost 50 pounds in a year. The drug helped me focus on being a new mom and gaining strength at the gym, not just counting calories burned."
"It felt like a double punch. And that's kind of the point where I was like, 'I guess I can't make it work.' I felt defeated."
"That was the first moment that I was like, holy cow, these insurance companies, they're now making medical decisions for me. And that really, really made me mad."
Meghan Lena, a Massachusetts special ed teacher, lost coverage for her obesity medication Zepbound, which helped her lose 50 pounds. After switching to Wegovy, her employer's health plan dropped it too, leading to feelings of defeat. Her health insurance premium also increased by 20%. Research by GoodRx indicates that millions are losing coverage for these medications, highlighting a troubling trend where insurance companies dictate medical options for patients, causing frustration and concern among those affected.
Read at www.npr.org
Unable to calculate read time
[
|
]